CASE STUDY: METHODOLOGY IN BUILDING INFORMATION AND EDUCATION RESOURCES FOR A NATIONAL SCREENING PROGRAM Supporting participation paramount in the upcoming National Lung Cancer Screening Program
With
Dr Rachael Dodd
Senior Research Fellow,
The Daffodil Centre, a Cancer Council NSW & The University of Sydney Joint Venture
AUSTRALIAN HEALTH JOURNAL CASE STUDY
Filmed in Sydney | April 2025
At the recent Screening Conference 2025 in Sydney, hosted by Public Health Association, Dr Rachael Dodd, Senior Research Fellow at The Daffodil Centre, spoke about the information and educational resources created to increase awareness in the healthcare workforce and community on the upcoming Australia’s National Lung Cancer Screening Program commencing in July 2025.
A consortium including The Daffodil Centre, Lung Foundation Australia, Cancer Council Victoria and University of Melbourne were engaged by the Australian Government, through Cancer Australia to deliver a suite of information materials, workforce education resources, and a dissemination strategy for the Program, seen as paramount to support participation.
Dr Dodd talked to Australian Health Journal about the qualitative research process over the past 6 years, from a scoping review of existing lung cancer screening (LCS) information materials and messaging and an environmental scan of existing cancer screening program resources to inform initial development of the key messages, proposed information resources and the dissemination strategy. These were further developed through individual interviews and co-design workshops with the healthcare workforce and community members.
The scoping review identified 34 articles reporting strategies to increase awareness and knowledge of LCS. The environmental scan found 13 provider-focused resources and 18 consumer-focused resources across Australian screening programs. Most LCS-specific resources (18 sets) were from the United States, United Kingdom, Canada and Singapore.
Key ideas arising from the consultations (28 community; 35 health workforce) and co-design workshops (2 health workforce (n=41), 1 community (n=18)) were the need for: clear information about eligibility criteria, a pack-year smoking calculator, easy-to-read detail about the National Cancer Screening Register, examples of symptoms of lung cancer, clarity on referral pathways, a centralised website to host resources, videos of the screening process, guidance for ineligible participants, and managing conversations including smoking behaviours, and lung cancer stigma. Digital resources were generally preferred to paper resources.
Source: Adapted from Screening Conference 2025 Abstract Book
-
Specialist emergency care clinics in rollout
Unlike Emergency Departments that operate within public hospitals and some private hospitals, a Walk-in Specialist Emergency Clinic is located in the community and designed to provide comprehensive, coordinated acute care – from initial consultation and diagnostic services, to treatment and specialist referral if required – without the patient having to visit a hospital.
Australian Health Journal spoke to the visionary, founder and CEO behind this WiSE Specialist Emergency clinic, Dr Pankaj Arora.
-
Misinformation impacts routine vaccines
More significant changes in recent years have been health-related misinformation eroding trust in healthcare professionals, leading to people seeking alternative treatments or avoiding medical advice altogether. This can make it more difficult for healthcare professionals to provide effective treatment and care.
Recent vaccines delivered as part of the COVID-19 response, are having a consequential impact on the uptake of routine vaccines.
Australian Health Journal spoke with Dr Paul Griffin, an Infectious Diseases Physician and Microbiologist at Mater Health, and who has been involved in over 150 clinical trials in the field of infectious disease.
Paul talks about the importance of having reputable sources of information that can used to encourage people to understand what is involved in clinical trials and the roles of vaccines.
-
Ensuring stringent quality standards in the lifecycle of medical devices
Dr Jasjit Baveja is the Associate Director of Policy at the Medical Technology Association of Australia (MTAA), where she oversees regulatory affairs, clinical code of practice, procurement, industry policy, reimbursement, and advocacy. With over 20 years of experience in the medical device regulatory space, Dr Bavej’s expertise lies in providing educational opportunities for regulatory professionals in Australia to ensure continuous learning and professional development. She collaborates closely with the Therapeutic Goods Administration (TGA) to run workshops that provide invaluable experience, networking opportunities, and skill enhancement.
